Celularity (CELUW) Cash from Investing Activities (2019 - 2024)
Celularity (CELUW) reported Cash from Investing Activities of -$1.6 million for Q4 2024, down 174.31% year-over-year from $2.1 million in Q1 2024, and down 174.21% quarter-over-quarter from $2.1 million in Q2 2024.
Celularity (CELUW) Cash from Investing Activities (2019 - 2024) Analysis & Trends
Celularity (CELUW) has 6 years of Cash from Investing Activities data on file, last reported at -$1.6 million in Q4 2024.
- Cash from Investing Activities for Q4 2024 came in at -$1.6 million, down 174.31% year-over-year; the trailing twelve-month figure through Dec 2024 was $514000.0 (up 112.7% YoY), and the FY2024 annual result was $514000.0, up 112.7% from the prior year.
- Cash from Investing Activities declined to -$1.6 million in Q4 2024 per CELUW's latest filing, from $2.1 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $2.1 million in Q2 2024 and troughed at -$9.4 million in Q4 2020.
- A 5-year average of -$1.4 million and a median of -$1.1 million in 2021 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2020 and 2024: Cash from Investing Activities tumbled 8179.31% in 2020, then jumped 7016.13% in 2024.
- A 5-year view of Cash from Investing Activities shows it stood at -$9.4 million in 2020, then jumped by 75.43% to -$2.3 million in 2021, then soared by 66.17% to -$779000.0 in 2022, then gained by 25.55% to -$580000.0 in 2023, then sank by 174.31% to -$1.6 million in 2024.
- Business Quant data shows CELUW's Cash from Investing Activities at -$1.6 million in Q4 2024, $2.1 million in Q2 2024, and -$39000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.89 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 638.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -431.90 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 579,519.10 |
| 10 | Celularity | - | - | -3.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1.59 Mn |
| Dec 31, 2024 | -1.59 Mn |
| Jun 30, 2024 | 2.14 Mn |
| Jun 30, 2024 | 2.14 Mn |
| Mar 31, 2024 | -39,000.00 |
| Mar 31, 2024 | -39,000.00 |
| Dec 31, 2023 | -580,000.00 |
| Dec 31, 2023 | -580,000.00 |
| Sep 30, 2023 | -228,000.00 |
| Sep 30, 2023 | -228,000.00 |
| Jun 30, 2023 | -31,000.00 |
| Jun 30, 2023 | -31,000.00 |
| Mar 31, 2023 | -3.21 Mn |
| Mar 31, 2023 | -3.21 Mn |
| Dec 31, 2022 | -779,000.00 |
| Dec 31, 2022 | -779,000.00 |
| Sep 30, 2022 | -1.56 Mn |
| Sep 30, 2022 | -1.56 Mn |
| Jun 30, 2022 | -1.44 Mn |
| Jun 30, 2022 | -1.44 Mn |